去年，Tandem Diabetes Care Inc表现最佳的业务板块Pump实现营收706.94M美元。Domestic的营收贡献最高，去年达到353.88M美元。最近一个季度，截至2026-06-30，Tandem Diabetes Care Inc表现最佳的业务板块Pump实现营收114.65M美元。Domestic的营收贡献最高，达到83.00M美元。

业务

营业收入

占比

年报

年报

单季报

Pump

Supplies and other - Domestic

Supplies and other-International

Deferral for Tandem Choice program-Domestic

Infusion sets

Cartridges

Other

Adjustment for Tandem Choice program

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Pump

706.94M(69.67%)

434.17M(46.18%)

374.29M(49.50%)

431.91M(53.91%)

416.36M(59.24%)

314.71M(63.09%)

247.59M(68.34%)

Supplies and other - Domestic

197.54M(19.47%)

161.97M(17.23%)

116.54M(15.41%)

--(--)

Supplies and other-International

110.26M(10.87%)

313.81M(33.38%)

290.44M(38.41%)

--(--)

Deferral for Tandem Choice program-Domestic

--(--)

30.25M(3.22%)

-25.11M(-3.32%)

--(--)

Infusion sets

--(--)

258.49M(32.26%)

197.45M(28.09%)

127.76M(25.61%)

77.25M(21.32%)

Cartridges

--(--)

112.16M(14.00%)

86.88M(12.36%)

55.23M(11.07%)

36.68M(10.12%)

Other

--(--)

2.21M(0.28%)

2.11M(0.30%)

1.14M(0.23%)

786.00K(0.22%)

Adjustment for Tandem Choice program

--(--)

-3.55M(-0.44%)

--(--)

地区

营业收入

占比

年报

年报

单季报

Domestic

International

Adjustment for Tandem Choice program

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Domestic

353.88M(50.06%)

328.63M(75.69%)

289.55M(77.36%)

592.31M(73.60%)

524.91M(74.69%)

415.68M(83.33%)

302.08M(83.38%)

International

353.06M(49.94%)

105.54M(24.31%)

84.75M(22.64%)

212.45M(26.40%)

177.89M(25.31%)

83.15M(16.67%)

60.22M(16.62%)

Adjustment for Tandem Choice program

--(--)